1-(3-aminopropyl)imidazole

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Hoven, Voravee P: 1 article (01/2020)
2.	Kiatkamjornwong, Suda: 1 article (01/2020)
3.	Palaga, Tanapat: 1 article (01/2020)
4.	Pinyakit, Yuwaporn: 1 article (01/2020)

1.	Neoplasms (Cancer) 01/01/2020 - "Then, 1-(3-aminopropyl)imidazole (API), a reagent to introduce charge conversional entities, was reacted with the remaining PPFPA segment in the micellar core resulting in API-modified micelles which can encapsulate doxorubicin (DOX), a hydrophobic anti-cancer drug. "

1.	Micelles
2.	Indicators and Reagents (Reagents)
3.	Doxorubicin (Adriamycin)